H. Farhat

发表

Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity

J. Georges, B. Livarek, N. Baron, 2017, European heart journal cardiovascular Imaging.

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

R. Bouabdallah, H. Dombret, S. Chevret, 2007, Leukemia.

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

G. Salles, R. Bouabdallah, A. Stamatoullas, 2015 .

Angiotensin-converting enzyme inhibitor-induced angioedema may not be a class-related event: Case study

H. Farhat, 2012 .

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70‐year old: A phase 1/2 study of the acute leukemia French association

H. Dombret, S. Chevret, C. Gardin, 2012, American journal of hematology.

Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy for the prediction of subsequent cardiotoxicity.

J. Georges, B. Livarek, N. Baron, 2016, Annales de cardiologie et d'angeiologie.

Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia

P. Cony-Makhoul, S. de Botton, P. Rousselot, 2018, Leukemia & lymphoma.

The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic Patients

P. Rousselot, A. Jannot, S. Rigaudeau, 2016, Infection Control & Hospital Epidemiology.

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

A. Vekhoff, L. Adès, C. Cordonnier, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study.

J. Zahar, E. Chachaty, G. Nitenberg, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: A Prospective Randomized Study.

A. Vekhoff, S. Leprêtre, L. Adès, 2006 .

Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model

B. Farley, A. Vekhoff, S. Leprêtre, 2013, PloS one.

[Two cases of Bacillus infection and immunodepression].

J. Zahar, E. Chachaty, G. Nitenberg, 2008, Medecine et maladies infectieuses.

Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review

P. Rousselot, H. Farhat, C. Besson, 2020, EJHaem.

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

R. Bouabdallah, A. Stamatoullas, P. Feugier, 2019, The Lancet. Oncology.

Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index

F. Jardin, H. Tilly, S. Chevret, 2014, Genes, chromosomes & cancer.

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

P. Rousselot, M. Delord, S. Rigaudeau, 2021, Haematologica.

Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results

L. Adès, N. Vey, S. Glaisner, 2018, Blood.

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial

Sylvie Chevret, Claude Preudhomme, Hassan Farhat, 2014, Oncotarget.

Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 cases

V. Eclache, V. Leblond, P. Rousselot, 2006, Leukemia.

Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse

C. Preudhomme, P. Rousselot, Aline Renneville, 2014, American journal of hematology.

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older.

F. Jardin, G. Salles, P. Feugier, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)

F. Jardin, B. Coiffier, H. Tilly, 2014 .

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.

F. Jardin, B. Coiffier, H. Tilly, 2017, The Lancet. Haematology.

Hodgkin's disease primarily involving the oropharynx: case report and review of the literature.

Hassan Farhat, Daniel Vanel, Jacques Bosq, 2002, The hematology journal : the official journal of the European Haematology Association.

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy. an Interim Analysis of the GRAALL AFR09 Trial.

H. Dombret, E. Macintyre, A. Delannoy, 2004 .

The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic Patients

P. Rousselot, A. Jannot, S. Rigaudeau, 2016, Infection Control & Hospital Epidemiology.

Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy , for the prediction of subsequent cardiotoxicity

J. Georges, B. Livarek, N. Baron, 2017 .